000 | 01235 a2200337 4500 | ||
---|---|---|---|
005 | 20250517152921.0 | ||
264 | 0 | _c20180326 | |
008 | 201803s 0 0 eng d | ||
022 | _a1950-6007 | ||
024 | 7 |
_a10.1016/j.biopha.2017.04.105 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAlMatar, Manaf | |
245 | 0 | 0 |
_aNew drugs for the treatment of Mycobacterium tuberculosis infection. _h[electronic resource] |
260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cJul 2017 |
||
300 |
_a546-558 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 | _aDrug Repositioning |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 |
_aRNA, Antisense _xtherapeutic use |
650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
700 | 1 | _aAlMandeal, Husam | |
700 | 1 | _aVar, Işıl | |
700 | 1 | _aKayar, Begüm | |
700 | 1 | _aKöksal, Fatih | |
773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 91 _gp. 546-558 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2017.04.105 _zAvailable from publisher's website |
999 |
_c27151895 _d27151895 |